Charles Schoch's most recent trade in Candel Therapeutics Inc was a trade of 5,353 Common Stock done at an average price of $4.7 . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Charles Schoch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 4.67 per share. | 25 Jun 2025 | 5,353 | 43,391 | - | 4.7 | 24,999 | Common Stock |
| Candel Therapeutics Inc | Charles Schoch | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 8.83 per share. | 17 Mar 2025 | 5,000 | 38,038 | - | 8.8 | 44,169 | Common Stock |
| Candel Therapeutics Inc | Charles Schoch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 83,000 | 83,000 | - | - | Stock Option (Right to Buy) | |
| Candel Therapeutics Inc | Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 7.23 per share. | 15 Jan 2025 | 9,511 | 43,038 | - | 7.2 | 68,717 | Common Stock |
| Candel Therapeutics Inc | Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 6.47 per share. | 17 Jul 2024 | 9,884 | 62,520 | - | 6.5 | 63,975 | Common Stock |
| Candel Therapeutics Inc | Charles Schoch | See Remarks | Sale of securities on an exchange or to another person at price $ 5.97 per share. | 11 Jul 2024 | 8,897 | 72,404 | - | 6.0 | 53,145 | Common Stock |